IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,960,369 | -75.2% | 203,569 | -72.5% | 0.00% | -76.5% |
Q2 2023 | $7,888,911 | +10.2% | 741,439 | +8.9% | 0.02% | +6.2% |
Q1 2023 | $7,160,985 | -12.3% | 680,702 | +3.3% | 0.02% | -15.8% |
Q4 2022 | $8,167,451 | +36.8% | 659,197 | +14.4% | 0.02% | +26.7% |
Q3 2022 | $5,971,000 | +14.4% | 576,388 | +27.3% | 0.02% | +25.0% |
Q2 2022 | $5,219,000 | -8.3% | 452,672 | +0.1% | 0.01% | +9.1% |
Q1 2022 | $5,689,000 | +13.7% | 452,191 | +5.4% | 0.01% | +22.2% |
Q4 2021 | $5,004,000 | +13.6% | 429,131 | +27.2% | 0.01% | +12.5% |
Q3 2021 | $4,406,000 | -25.7% | 337,365 | -26.8% | 0.01% | -20.0% |
Q2 2021 | $5,929,000 | -1.9% | 460,688 | -14.8% | 0.01% | 0.0% |
Q1 2021 | $6,042,000 | +53.6% | 540,473 | +56.5% | 0.01% | +42.9% |
Q4 2020 | $3,934,000 | +53.6% | 345,367 | +21.3% | 0.01% | +75.0% |
Q3 2020 | $2,561,000 | -43.7% | 284,715 | -35.4% | 0.00% | -42.9% |
Q2 2020 | $4,550,000 | +67.4% | 440,921 | +63.7% | 0.01% | +40.0% |
Q1 2020 | $2,718,000 | +38.8% | 269,390 | +83.1% | 0.01% | +150.0% |
Q4 2019 | $1,958,000 | +336.1% | 147,113 | +181.6% | 0.00% | +100.0% |
Q3 2019 | $449,000 | -72.6% | 52,243 | -65.1% | 0.00% | -50.0% |
Q2 2019 | $1,640,000 | +128.1% | 149,888 | +181.9% | 0.00% | +100.0% |
Q1 2019 | $719,000 | +257.7% | 53,169 | +297.1% | 0.00% | – |
Q4 2017 | $201,000 | -53.7% | 13,389 | -51.3% | 0.00% | -100.0% |
Q3 2017 | $434,000 | -58.2% | 27,498 | -50.0% | 0.00% | 0.0% |
Q2 2017 | $1,039,000 | +10.6% | 55,047 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $939,000 | +32.3% | 55,047 | +18.6% | 0.00% | 0.0% |
Q4 2016 | $710,000 | +10.8% | 46,418 | +15.1% | 0.00% | 0.0% |
Q3 2016 | $641,000 | +118.0% | 40,343 | +65.8% | 0.00% | 0.0% |
Q2 2015 | $294,000 | -64.2% | 24,338 | -52.6% | 0.00% | -50.0% |
Q1 2015 | $822,000 | +5.0% | 51,400 | +0.6% | 0.00% | 0.0% |
Q4 2014 | $783,000 | -2.4% | 51,100 | -17.4% | 0.00% | 0.0% |
Q3 2014 | $802,000 | – | 61,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |